Karmanos Cancer Institute is a clinical research site located in Farmington Hills, Michigan, United States 48334.
Crixeo Clinical Trials Trust Score: 17/100 (FAILING). This profile has not yet been claimed by the site owner.
Karmanos Cancer Institute has participated in 10 clinical trials with 2 currently active.
Therapeutic areas: Carcinoma, Non-Small-Cell Lung, Squamous Cell Carcinoma of the Head and Neck, Esophageal Squamous Cell Carcinoma.
Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Incyte Corporation, Pfizer.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Michigan · View every site in Farmington Hills
Trust Score: 17/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Karmanos Cancer Institute has a Crixeo Trust Score of 17/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Karmanos Cancer Institute has 10 clinical trials on record, with 2 currently active. Their work covers Carcinoma, Non-Small-Cell Lung, Squamous Cell Carcinoma of the Head and Neck, Esophageal Squamous Cell Carcinoma.
Karmanos Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.